Study identifies brain abnormalities in people with schizophrenia

July 7, 2015
Functional magnetic resonance imaging (fMRI) and other brain imaging technologies allow for the study of differences in brain activity in people diagnosed with schizophrenia. The image shows two levels of the brain, with areas that were more active in healthy controls than in schizophrenia patients shown in orange, during an fMRI study of working memory. Credit: Kim J, Matthews NL, Park S./PLoS One.

Structural brain abnormalities in patients with schizophrenia, providing insight into how the condition may develop and respond to treatment, have been identified in an internationally collaborative study led by a Georgia State University scientist.

Scientists at more than a dozen locations across the United States and Europe analyzed brain MRI scans from 2,028 and 2,540 healthy controls, assessed with standardized methods at 15 centers worldwide. The findings, published in Molecular Psychiatry, help further the understanding of the .

The work was the outcome of the Enhancing Neuroimaging Genetics through Meta-Analysis project (ENIGMA), from the Schizophrenia Working Group that is co-chaired by Jessica Turner, associate professor of psychology and neuroscience at Georgia State, and Theo van Erp, assistant research professor in psychiatry at the University of California, Irvine.

"This is the largest structural brain meta-analysis to date in , and specifically, it is not a meta-analysis pulled only from the literature," said Turner. "Investigators dug into their desk drawers, including unpublished data to participate in these analyses. Everyone performed the same analyses using the same statistical models, and we combined the results. We then identified brain regions that differentiated patients from controls and ranked them according to their effect sizes."

The team found individuals with schizophrenia have smaller volume in the hippocampus, amygdala, thalamus, nucleus accumbens and intracranial space than controls, and larger pallidum and ventricle volumes. The study validates collaborative data analyses can be used across brain phenotypes and disorders, and encourages analysis and data-sharing efforts to further understanding of severe mental illness.

The ENIGMA collaborations include working groups for other disorders such as bipolar disorder, attention deficit, major depression, autism and addictions, who are all doing these same analyses.

The next step in this research is to compare the effects across disorders, to identify which brain region is the most affected in which disorder, and to determine the effects of age, medication, environment and symptom profiles across these disorders.

"There's the increased possibility, not just because of the massive datasets, but also because of the collaborative power being applied here from around the world, that we will find something real and reliable that will change how we think about these disorders and what we can do about them," Turner said.

Explore further: Study identifies biological mechanisms for schizophrenia, bipolar disorder and depression

Related Stories

Study identifies biological mechanisms for schizophrenia, bipolar disorder and depression

January 29, 2015
Common psychiatric disorders such as schizophrenia, bipolar disorder and major depression share genetic risk factors related to immune function and DNA regulation, according to new findings by a large collaborative research ...

How a risk gene for schizophrenia affects the brain

May 25, 2015
Scientists have for the first time shown how the disruption of a key gene involved in mental illness impacts on the brain.

Advanced MRI scans could help predict people at risk of schizophrenia

May 11, 2015
New scanning methods which map the wiring of the brain could provide a valuable new tool to predict people at risk of schizophrenia, according to a new study.

Brain networks differ among those with severe schizophrenia, study shows

March 18, 2015
People with a severe form of schizophrenia have major differences in their brain networks compared to others with schizophrenia, bipolar disorder and healthy individuals, a new study from the Centre for Addiction and Mental ...

Patients with recurrent depression have smaller hippocampi

June 29, 2015
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people ...

Brain development in schizophrenia strays from the normal path

September 15, 2014
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.

Recommended for you

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

Schizophrenia disrupts the brain's entire communication system, researchers say

October 17, 2017
Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

For older adults, volunteering could improve brain function

October 17, 2017
Older adults worried about losing their cognitive functions could consider volunteering as a potential boost, according to a University of Missouri researcher. While volunteering and its associations with physical health ...

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.